Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05483192Not ApplicableCompleted

Impact of Oral Dyglomera™ on Body Fat and Blood Lipids of Overweight and Obese Adults

Role: lead

NCT01564381Phase 1Completed

Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women

Role: collaborator

NCT00645775Not ApplicableCompleted

Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome

Role: lead

NCT00526682Not ApplicableCompleted

The Use of Irvingia Gabonensis (Bush Mango)and Cissus Quadrangularis to Reduce Weight and Blood Lipids

Role: lead

All 4 trials loaded